Mitomycin C-induced renal insufficiency: A case report

Kaohsiung Journal of Medical Sciences

Volumn 19, Issue 6, 2003, Pages 317-320

  Wen, Mei Chin ^a   Chen, Cheng Hsu ^a   Ho, William L ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hemolytic uremic syndrome; Mesangiolysis; Mitomycin C; Nephrotoxicity; Thrombotic microangiopathy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; MITOMYCIN C;

ADULT; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CASE REPORT; CYTOLYSIS; GLOMERULUS CAPILLARY; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MALE; MESANGIUM CELL; PLASMAPHERESIS; STOMACH CANCER; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR RECURRENCE; VASODILATATION;

EID: 0037491976     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70479-6     Document Type: Article

References (16)

1. Crooke ST, Bradner WT. Mitomycin C: a review. Cancer Treat Rev 1976;3:121-39.
2. Buzdar AU, Legha SS, Tashima CK, et al. Adriamycin and mitomycin C: possible synergistic cardiotoxicity. Cancer Treat Rep 1978;62:1005-8.
3. Buzdar AU, Legha SS, Luna MA, et al. Pulmonary toxicity of mitomycin. Cancer 1980;45:236-44.
4. Liu K, Mittelman A, Sproul EE, Elias EG. Renal toxicity in man treated with mitomycin C. Cancer 1971;28:1314-20.
5. Hanna WT, Krauss S, Regester RF, Murphy WM. Renal disease after mitomycin C therapy. Cancer 1981;48:2583-8.
6. Giroux L, Bettez P, Giroux L. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. Am J Kidney Dis 1985;6: 28-39.
7. Proia AD, Harden EA, Silberman HR. Mitomycin-induced hemolytic-uremic syndrome. Arch Pathol Lab Med 1984;108: 959-62.
8. Shiiki H, Dohi K, Nishioka H, et al. Glomerular tuft ballooning in mitomycin-C-induced renal impairment. Virchows Archiv A Pathol Anat 1992;420:545-51.
9. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-9.
10. Mungall S, Mathieson P. Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate. Am J Kidney Dis 2002;40:1334-6.
11. Citarrella P, Gebbia V, Teresi M, et al. Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report. Anticancer Res 2002;22:1183-5.
12. Wilson JKV. Pulmonary toxicity of antineoplastic drugs. Cancer Treat Rep 1978;62:2003-8.
13. Morita T, Kihara I, Oite T, et al. Mesangiolysis: sequential ultrastructure study of Habu venom-induced glomerular lesions. Lab Invest 1978;38:94-102.
14. Antignac C, Gubler MC, Leverger G, et al. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 1989;35:1336-44.
15. Wu DC, Liu JM, Chen YM, et al. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. Jpn J Clin Oncol 1997;27:115-8.
16. Duvic C, Sarret D, Coutant G, et al. Hemolytic-uremic syndrome caused by mitomycin C: long-term management. Ann Med Interne 2000;151:70-3. [In French]